Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane versus remimazolam for myocardial injury in minimally invasive mitral valve surgery
jRCT1031260637Not yet recruiting
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sevoflurane and remimazolam in mitral valve disease (2 arms). Primary endpoint: Delta high-sensitivity troponin I. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
sevofluraneremimazolam
03
Conditions
mitral valve disease
Beyond the preview
Go deeper on jRCT1031260637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031260637.